http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9122785-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f34119b232d292c72e632b62008eca90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95ab7b10627e9b4c0d30ff22389f5852
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24cc50cd206e2b7975587e712ef1dda4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0da759d7c9221df686e77f869f2c5a4e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B34-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B19-56
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-3468
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-14276
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H40-67
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B19-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H40-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-142
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06T11-20
filingDate 2010-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4464c5fe3669846b13f7b5713653fc43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d153890b15e7e30100d7d56a476932d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c65ade3435b5f539239091dd88accbda
publicationDate 2015-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-9122785-B2
titleOfInvention Display of supplemental bolus in relation to programmed dose
abstract Techniques are described for displaying a representation of a supplemental bolus and a representation of programmed doses of a therapy schedule for an implantable fluid delivery device with a programmer device. In one example, a device includes a user interface to present a graphical representation of doses of fluid to be delivered to a patient via an implantable fluid delivery device and a processor that controls the user interface to simultaneously present a first graphical representation of a supplemental bolus to be delivered by the implantable fluid delivery device and a second graphical representation of programmed doses of a therapy schedule of the implantable fluid delivery device, wherein at least a portion of the programmed doses of the therapy schedule follows delivery of the supplemental bolus by the implantable fluid delivery device. A user of the device may determine whether the representations indicate an excessive dosage risk to the patient.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11744939-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11229778-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11147918-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11344714-B2
priorityDate 2009-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008249470-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03099355-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6007493-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012209241-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008033402-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011264071-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5925066-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006272652-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002193679-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010064243-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005009514-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006041222-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1022035-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006206066-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014032549-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005283210-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5722999-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008286330-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013274709-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6675044-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394766
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414514
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395290
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2474
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127963844
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409108
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5288826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397536
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2803
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284570
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44600

Total number of triples: 69.